PAVMW Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 jan 2022 @ 18:36):

Stats
Dagens volum	32 626
Gjennomsnittsvolum	6 563
Markedsverdi	769 747
EPS	$-1.750 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500 (Sector) 42.63 (Industry) 43.86
ATR14	$0.0950 (327.59%)

ABMD 0.00%

AMIX -2.65%

BBLGW -19.30%

BVS 1.19%

COCH 0.43%

DHAI -4.91%

DHAIW 0.00%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -2.26%

HSCSW 19.64%

IINNW -27.42%

INVO -6.67%

LFWD 0.49%

MDAI 1.82%

MGRM -2.86%

MXCT -2.81%

NVNOW -32.98%

NXL 25.66%

NXLIW -25.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ -4.76%

PETVW 0.00%

QTI 1.57%

QTNT 0.00%

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: -0.15 (neutral)

Signal:(30.313) Neutral

PAVmed Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PAVmed Inc. Korrelasjon - Valuta/Råvare

-0.64
( weak negative )

-0.11
( neutral )

-0.77
( moderate negative )

-0.42
( neutral )

0.13
( neutral )

0.89
( strong )

PAVmed Inc. Økonomi

Annual	2023
Omsetning:	$2.45M
Bruttogevinst:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2023
Omsetning:	$2.45M
Bruttogevinst:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2022
Omsetning:	$377 000
Bruttogevinst:	$-3.24M (-858.62 %)
EPS:	$-17.06

FY	2021
Omsetning:	$500 000
Bruttogevinst:	$-85 000.00 (-17.00 %)
EPS:	$-1.897

Financial Reports:

No articles found.

PAVmed Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company\'s lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett\'s Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.